- Title
- Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects
- Creators
- Rajesh GARG - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesYuvraj KUMBKARNI - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesAhmad ALJADA - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesPriya MOHANTY - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesHusam GHANIM - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesWael HAMOUDA - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United StatesParesh DANDONA - Diabetes-Endocrinology Center of Western New York, Buffalo, NY, United States
- Publication Details
- Hypertension (Dallas, Tex. 1979), Vol.36(3), pp.430-435
- Publisher
- Lippincott; Philadelphia, PA; Hagerstown, MD
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Endocrinology, Diabetes & Metabolism
- Language
- English
- Resource Type
- Journal article
- PMID
- 10988277
- Record Identifier
- 991031560053102976
Journal article
Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects
Hypertension (Dallas, Tex. 1979), Vol.36(3), pp.430-435
2000
PMID: 10988277
Metrics
13 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.141 Hormone Therapy
- 1.141.407 Acute Promyelocytic Leukemia
- Web Of Science research areas
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites